Fifth Third Bancorp’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77K | Buy |
2,137
+344
| +19% | +$12.4K | ﹤0.01% | 1248 |
|
|
2025
Q1 | $55.8K | Buy |
1,793
+263
| +17% | +$8.19K | ﹤0.01% | 1351 |
|
|
2024
Q4 | $39K | Buy |
1,530
+997
| +187% | +$25.4K | ﹤0.01% | 1480 |
|
|
2024
Q3 | $15.1K | Buy |
533
+92
| +21% | +$2.6K | ﹤0.01% | 1870 |
|
|
2024
Q2 | $11.6K | Sell |
441
-23
| -5% | -$607 | ﹤0.01% | 1884 |
|
|
2024
Q1 | $14.1K | Sell |
464
-5,434
| -92% | -$165K | ﹤0.01% | 1770 |
|
|
2023
Q4 | $166K | Buy |
5,898
+170
| +3% | +$4.78K | ﹤0.01% | 1017 |
|
|
2023
Q3 | $155K | Buy |
5,728
+242
| +4% | +$6.57K | ﹤0.01% | 1013 |
|
|
2023
Q2 | $169K | Sell |
5,486
-23
| -0.4% | -$707 | ﹤0.01% | 1002 |
|
|
2023
Q1 | $198K | Buy |
5,509
+52
| +1% | +$1.87K | ﹤0.01% | 1017 |
|
|
2022
Q4 | $216K | Sell |
5,457
-12
| -0.2% | -$474 | ﹤0.01% | 921 |
|
|
2022
Q3 | $219K | Buy |
5,469
+12
| +0.2% | +$481 | ﹤0.01% | 920 |
|
|
2022
Q2 | $229K | Hold |
5,457
| – | – | ﹤0.01% | 911 |
|
|
2022
Q1 | $213K | Buy |
5,457
+1,707
| +46% | +$66.6K | ﹤0.01% | 982 |
|
|
2021
Q4 | $149K | Buy |
+3,750
| New | +$149K | ﹤0.01% | 1107 |
|
|
2021
Q3 | – | Sell |
-251
| Closed | -$10K | – | 2731 |
|
|
2021
Q2 | $10K | Buy |
+251
| New | +$10K | ﹤0.01% | 2018 |
|
|
2021
Q1 | – | Sell |
-2,000
| Closed | -$100K | – | 2484 |
|
|
2020
Q4 | $100K | Hold |
2,000
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q3 | $84K | Hold |
2,000
| – | – | ﹤0.01% | 1161 |
|
|
2020
Q2 | $97K | Buy |
+2,000
| New | +$97K | ﹤0.01% | 1107 |
|